Stockscreener 앱 받기
101.88
0.43%
-0.44
Merck Co Inc 주식(MRK)의 최신 뉴스
Lowe Brockenbrough & Co. Inc. Sells 10,077 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q3 2024 Earnings Call Transcript - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease - Yahoo Finance UK
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.9% Following Analyst Downgrade - MarketBeat
Meitav Investment House Ltd. Sells 325,858 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck Animal Health unveils ALLFLEX® APR series handheld readers - www.thecattlesite.com
Merck & Co Inc (MRK) Q3 2024 Earnings Call Highlights: Strong Oncology and Animal Health ... - Yahoo Finance
Merck & Co. Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Trending : Merck & Co. Lowers 2024 Adjusted EPS Outlook - Marketscreener.com
Merck & Co., Inc. (NYSE:MRK) Trading Down 2.9%Here's Why - MarketBeat
Merck tops Q3 earnings forecasts despite slower Gardasil demand - ShareCast
Merck & Co., Inc. (NYSE:MRK) Sets New 52-Week LowShould You Sell? - MarketBeat
Merck sees Gardasil China woes carrying into 2025 - Reuters
Merck & Co Inc (MRK) Stock Price Down 3.41% on Oct 31 - GuruFocus.com
Merck & Co. (MRK) Narrows Sales Outlook With Gardasil Shot Lagging in China - Bloomberg
Merck stock on watch after Q3 results (update) (MRK:NYSE) - Seeking Alpha
Infographic: How Merck (MRK) performed in Q3 2024 - AlphaStreet
Bristol Myers Squibb stock rises, Merck moves lower. Here's why. - Yahoo Finance
Merck Lowers Full-Year Sales Guidance Despite Strong Overall Q3 Results - BioSpace
Merck & Co., Inc. (NYSE:MRK) Updates FY 2024 Earnings Guidance - MarketBeat
Merck third quarter better than expected, but Gardasil sales sag in China again - Marketscreener.com
Merck tops estimates despite muted Gardasil and diabetes drug sales - Proactive Investors Australia
Merck: adjusted net income close to $4 billion in Q3 - Marketscreener.com
Merck & Co., Inc. (NYSE:MRK) Shares Acquired by JFS Wealth Advisors LLC - MarketBeat
Merck: Q3 Earnings Snapshot - Marketscreener.com
Merck's Q3 sales up 4% to $16.7 billion - baha news
Merck Announces Third-Quarter 2024 Financial Results - Business Wire
Merck & Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Down 0.1%Should You Sell? - MarketBeat
Merck & Co., Inc. (MRK): A Bull Case Theory - Insider Monkey
SteelPeak Wealth LLC Has $7.40 Million Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Is Eli Lilly Stock a Buy? - The Motley Fool
Jim Cramer Thinks That Merck & Co., Inc. (MRK) Is ‘Too Low’ - Insider Monkey
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Up 0.3%Here's What Happened - MarketBeat
A Look Into Merck & Co Inc's Price Over Earnings - Benzinga
China Universal Asset Management Co. Ltd. Raises Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co. Inc. stock rises Monday, still underperforms market - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Trading Up 0.2%Here's What Happened - MarketBeat
Why Is Moderna Stock Trading Higher On Monday? - Benzinga
Merck: collaboration with Moderna in lung cancer - Marketscreener.com
Nisa Investment Advisors LLC Boosts Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (MRK): Among the Best Dow Stocks to Buy According to Analysts - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Shares Bought by Allworth Financial LP - MarketBeat
Merck & Co., Inc. (MRK): Among the Best Stocks to Buy for High Returns in 2024 - Insider Monkey
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Boston Trust Walden Corp - MarketBeat
Is Merck Stock Undervalued After Its Colossal Earnings Growth? - MSN
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
BetterInvesting™ Magazine Update on Merck (MRK) and Ball (BALL) - Marketscreener.com
Merck & Co., Inc. (NYSE:MRK) PT Lowered to $130.00 - MarketBeat
Merck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda Threat (MRK) - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.4%Here's What Happened - MarketBeat
Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.
Mediolanum International Funds Ltd Increases Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Arcus Begins Differentiating Its HIF-2a inhibitor Versus Merck’s Welireg - Scrip
Merck & Co., Inc. (NYSE:MRK) Shares Down 0.2%What's Next? - MarketBeat
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines - Benzinga
Merck (MRK): Patent Concerns and Earnings Forecast Cuts Impact Dow Performance - Insider Monkey
Assenagon Asset Management S.A. Buys 805,571 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Modifi acquired by Merck in $1.3B deal - BioWorld Online
Merck: EU approves two new indications for Keytruda - Marketscreener.com
0.88%
0.16%
자본화:
|
볼륨(24시간):